- Trials with a EudraCT protocol (109)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
109 result(s) found for: Covid.
Displaying page 1 of 6.
| EudraCT Number: 2020-002668-29 | Sponsor Protocol Number: 132796 | Start Date*: 2020-06-25 |
| Sponsor Name:University College London | ||
| Full Title: A Randomised Controlled Trial of plasma exchange with standard of care compared to standard of care alone in the treatment of severe COVID-19 infection (COVIPLEX) | ||
| Medical condition: COVID-19 | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (GB - no longer in EU/EEA) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-001319-26 | Sponsor Protocol Number: FJD-COVID-ESTATINAS | Start Date*: 2020-05-14 |
| Sponsor Name:Instituto de Investigación Sanitaria Fundación Jiménez Díaz | ||
| Full Title: Multicenter, randomized, controlled, open-label clinical trial to assess the prognostic implications of rosuvastatin treatment in patients discharged after hospitalization for COVID-19 Positive. | ||
| Medical condition: COVID respiratory infection | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-001889-10 | Sponsor Protocol Number: STOIC | Start Date*: 2020-06-02 |
| Sponsor Name:University of Oxford, Clinical Trials and Research Governance | ||
| Full Title: Use of inhaled corticosteroids as treatment of early COVID-19 infection to prevent clinical deterioration and hospitalisation | ||
| Medical condition: COVID 19 | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (GB - no longer in EU/EEA) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-002310-41 | Sponsor Protocol Number: “MADRID-COVID” | Start Date*: 2020-06-15 |
| Sponsor Name:IIS FUNDACION JIMENEZ DIAZ | ||
| Full Title: Intravenous Metoprolol in Respiratory Distress Due to COVID-19: Pilot Study "MADRID-COVID" | ||
| Medical condition: The main objective of this pilot trial is to evaluate the effect of metoprolol on biological correlates of benefit of this therapy (inflammatory markers in blood and bronchoalveolar mini-lavage, mi... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-001405-23 | Sponsor Protocol Number: Ruxo-Sim-20 | Start Date*: 2020-04-11 | |||||||||||
| Sponsor Name:Fundación de Investigación HM Hospitales | |||||||||||||
| Full Title: Randomized phase II clinical trial of ruxolitinib plus simvastatin in the prevention and treatment of respiratory failure of COVID-19.Ruxo-Sim-20 clinical trial. | |||||||||||||
| Medical condition: COVID19 | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2020-002009-25 | Sponsor Protocol Number: SARSCov2EFTI1.0 | Start Date*: 2020-10-01 | |||||||||||
| Sponsor Name:Fakultni nemocnice Plzen | |||||||||||||
| Full Title: The efficacy and safety of Eftilagimod Alpha Treatment by immune modulation in COVID-19 disease (EAT COVID trial) | |||||||||||||
| Medical condition: COVID-19 disease | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: CZ (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2020-001605-23 | Sponsor Protocol Number: HUA-COVID-19 | Start Date*: 2020-05-29 |
| Sponsor Name:Basque Health Service | ||
| Full Title: Effectiveness of the combined treatment with hydroxycloroquine and azithromycin vs lopinavir/ritonavir + hydroxycloroquine in hospitalized patients with confirmed COVID-19 infection | ||
| Medical condition: Covid-19 infection | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-001678-31 | Sponsor Protocol Number: APHP200462 | Start Date*: 2020-04-28 |
| Sponsor Name:Assistance Publique Hopitaux de Paris | ||
| Full Title: Randomized controlled trial evaluating the efficacy of vaccination with Bacillus Calmette and Guérin (BCG) in the Prevention of COVID-19 via the strengthening of innate immunity in Health Care Work... | ||
| Medical condition: COVID 19 Health care workers (medical or non-medical) in French hospitals in direct contact with COVID-19 patients, including nurses, medical doctors and other personnel working in wards in charge... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-001198-55 | Sponsor Protocol Number: KronLungesyg_COVID_19_protokol_2 | Start Date*: 2020-04-03 | ||||||||||||||||
| Sponsor Name:Chronic Obstructive Pulmonary Disease Trial Network (COP:TRIN) | ||||||||||||||||||
| Full Title: Proactive Prophylaxis with Azithromycin and Hydroxychloroquine Patients Hospitalized with COVID | ||||||||||||||||||
| Medical condition: This trial will investigate infection with coronavirus (COVID-19) in patients who are admitted to hospital | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: DK (Ongoing) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2020-002037-15 | Sponsor Protocol Number: SARTRE | Start Date*: 2020-05-25 |
| Sponsor Name:Cristina Avendaño Sola | ||
| Full Title: Multicenter, randomized, open-label study to evaluate the efficacy and safety of SOC + Sarilumab versus Standard of Care for the Early Treatment of COVID-19-pneumonia in Hospitalized Patients | ||
| Medical condition: SARS-CoV-2 infected patients with pneumonia | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-001100-38 | Sponsor Protocol Number: BHV3241-301 | Start Date*: 2019-12-13 | |||||||||||
| Sponsor Name:Biohaven Pharmaceuticals, Inc | |||||||||||||
| Full Title: Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of BHV-3241 in Subjects with Multiple System Atrophy (M-STAR Study) | |||||||||||||
| Medical condition: Multiple System Atrophy | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Ongoing) DE (Ongoing) GB (GB - no longer in EU/EEA) AT (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2020-001565-37 | Sponsor Protocol Number: PrEP_COVID | Start Date*: 2020-04-03 |
| Sponsor Name:ISGlobal | ||
| Full Title: PRE-EXPOSURE PROPHYLAXIS WITH HYDROXYCHLOROQUINE FOR HIGH-RISK HEALTHCARE WORKERS DURING THE COVID-19 PANDEMIC (PrEP_COVID): A UNICENTRIC, DOUBLE-BLINDED RANDOMIZED CONTROLLED TRIAL. | ||
| Medical condition: COVID-19 | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-001303-16 | Sponsor Protocol Number: 7747 | Start Date*: 2020-04-11 |
| Sponsor Name:Hôpitaux Universitaires de Strasbourg | ||
| Full Title: Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on Survival in Elderly Hospitalized Patients with VIDOC-19 : A Randomized, Multi-Centre, Adaptive, Blinded Study | ||
| Medical condition: COVID-19 infection | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-001723-13 | Sponsor Protocol Number: 405 | Start Date*: 2020-04-17 |
| Sponsor Name:GROUPE HOSPITALIER PARIS SAINT-JOSEPH | ||
| Full Title: A randomized trial of efficacy and safety of an early OUTpatient treatment of COVID-19 in patients with risk factor for poor outcome : a strategy to prevent hospitalization : OUTCOV Study | ||
| Medical condition: COVID-19 patients with risk factor for poor outcome | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-001571-32 | Sponsor Protocol Number: APHP200406 | Start Date*: 2020-04-15 |
| Sponsor Name:Assistance Publique Hôpitaux de Paris | ||
| Full Title: Low dose of IL-2 In Acute respiratory DistrEss syndrome related to COVID-19 LILIADE-COVID | ||
| Medical condition: COVID-19 | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-002193-27 | Sponsor Protocol Number: COVID-AT | Start Date*: 2020-06-15 | ||||||||||||||||
| Sponsor Name:Cristina Avendano-Sola | ||||||||||||||||||
| Full Title: Double-blind, randomized, controlled, clinical trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 | ||||||||||||||||||
| Medical condition: COVID-related Acute Respiratory Distress Syndrome | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: ES (Ongoing) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2020-001904-41 | Sponsor Protocol Number: GETAFIX-2020 | Start Date*: 2020-05-20 | |||||||||||
| Sponsor Name:NHS Greater Glasgow and Clyde [...] | |||||||||||||
| Full Title: Glasgow Early Treatment Arm FavIpiravir : A randomized controlled study of favipiravir as an early treatment arm in COVID-19 patients | |||||||||||||
| Medical condition: COVID-19 | |||||||||||||
|
|||||||||||||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2020-001395-15 | Sponsor Protocol Number: Awaiting | Start Date*: 2020-04-06 | ||||||||||||||||
| Sponsor Name:Deparment of Intensive Care, Rigshospitalet | ||||||||||||||||||
| Full Title: Low dose hydrocortisone in patients with COVID-19 and severe hypoxia – the COVID STEROID trial | ||||||||||||||||||
| Medical condition: Adult patients with COVID-19 and severe hypoxia. | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2020-003349-12 | Sponsor Protocol Number: NUIG-2020-003 | Start Date*: 2020-10-09 |
| Sponsor Name:NUIG | ||
| Full Title: Can Nebulised HepArin Reduce acuTE lung injury in Patients with SARS-CoV-2 Requiring Mechanical Ventilation in Ireland | ||
| Medical condition: This trial will be carried out in invasively ventilated ICU patients with suspected or confirmed COVID-19 infection | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: IE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-002225-29 | Sponsor Protocol Number: AntagoBrad-Cov | Start Date*: 2020-11-12 | ||||||||||||||||
| Sponsor Name:Groupement de Coopération Sanitaire Ramsay Générale de Santé pour l’Enseignement et la Recherche | ||||||||||||||||||
| Full Title: Evaluation of the effects of bradykinin antagonists on pulmonary manifestations of COVID-19 infections. | ||||||||||||||||||
| Medical condition: COVID positive patients with respiratory impairment | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: FR (Ongoing) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
